Mithat Gunduz

Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance

Franco Lombardo, Nigel J. Waters, Upendra A. Argikar et al. · The Journal of Clinical Pharmacology · 2012 · 99 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Nalmefene Causes Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism

James H. Schluger, Ann Ho, Lisa Borg et al. · Alcoholism Clinical and Experimental Research · 1998 · 93 citations

Medicine, Endocrinology, Pharmacology +16

Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions

Mary Jeanne Kreek, James H. Schluger, L.A.H. Borg et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 91 citations

Medicine, Endocrinology, Pharmacology +17

Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 1: Volume of Distribution at Steady State

Franco Lombardo, Nigel J. Waters, Upendra A. Argikar et al. · The Journal of Clinical Pharmacology · 2012 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Naltrexone Biotransformation and Incidence of Subjective Side Effects: A Preliminary Study

Andrea C. King, Joseph R. Volpicelli, Mithat Gunduz et al. · Alcoholism Clinical and Experimental Research · 1997 · 71 citations

Medicine, Pharmacokinetics, Pharmacology +13